Navigation Links
Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
Date:11/29/2007

NEW YORK, Nov. 29 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX) and H. Lundbeck A/S today announced preliminary top-line results from a phase III study of LEXAPRO (escitalopram oxalate) in the treatment of adolescents, aged 12-17, with Major Depressive Disorder (MDD). These results indicate that patients treated with LEXAPRO experienced statistically significant improvement in symptoms of depression, as measured by the study's primary endpoint, the Children's Depression Rating Scale-Revised (CDRS-R), compared to placebo. The CDRS-R is a commonly used clinician-rated instrument that covers 17 symptom areas of depression relevant to adolescents, including impaired schoolwork, difficulty having fun, social withdrawal, physical complaints, and low self-esteem. Additional data from this study are expected to be presented in 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20001011/FORESTLOGO )

Researchers estimate that up to eight percent of adolescents are affected by depression.(1) However, FDA-approved treatment options for this population are limited. LEXAPRO is not currently approved by the FDA for use in pediatric patients.

"Depression is a significant problem among adolescents, and frequently goes under-recognized and under-treated in this age group. These data support that LEXAPRO has potential as an effective treatment option for adolescents with depression," said Ivan Gergel, M.D., Senior Vice President of Scientific Affairs and President of the Forest Research Institute.

About the Study

A double-blind, parallel-group, placebo-controlled phase III study to evaluate the safety and
'/>"/>

SOURCE Forest Laboratories, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
2. Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... -- Does your doctor know what you,re smoking?  Chances are, ... to the over 112,000 currently registered patients under ... other roughly 20,300+ active physicians listed with the Colorado Dept ... even though a poll in February 2014 showed 51% of ... it. "With marijuana legalization underway, every doctor ...
(Date:8/29/2014)... Md. , Aug. 29, 2014  United Therapeutics ... the U.S. District Court for the District of ... favor in the company,s case against Sandoz, Inc. regarding ... Peter Sheridan ruled that U.S. Patent No. ... and enjoined Sandoz from marketing its generic product until ...
(Date:8/29/2014)... , August 29, 2014 ... Market by Product & Services (Equipment, Reagent, Primer, ... Application (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, ... MarketsandMarkets, the global Oligonucleotide Synthesis Market is expected ... Million in 2014, growing at a CAGR of ...
Breaking Medicine Technology:Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4District Court Decision Received In Remodulin Patent Case 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4
(Date:8/30/2014)... 2014 Hands On Mobile ... offers the complete spa experience combining elegant decor, ... the most important ingredient of all, states Marla ... pro's! People will enjoy the get-away feel, without ... website reads, "Step into the spacious, luxurious spa ...
(Date:8/30/2014)... 2014 The Plastic Surgery Group (PSG) ... and even in the U.S. to provide clients with ... of patients’ waists with deep-tissue heating. , Unlike Cryotherapy ... Vanquish is more inclusive to target large sections of ... under panels about one inch away from their body ...
(Date:8/30/2014)... Jackson, Tenn. (PRWEB) August 30, 2014 ... people around the country for the past several ... the Tennessee Hyperbaric Center have announced a scholarship ... PTSD. This announcement follows a meeting held this ... , In recent years, reporters have shed light ...
(Date:8/30/2014)... Insomnia causes disturbances in every aspect of life. ... developed insomnia and the steps often used to return back ... to the show at this link: Dr. Carol Francis ... 30, and will be podcasted at this link (Click ... DrCarolFrancisTalkRadio.com. , "Insomnia causes countless unrecognized complications. Weight ...
(Date:8/30/2014)... "My wife suffered neck, back and spine injuries ... of two inventors from Bethel, Alaska. "The whiplash contributed ... area. She tried other pillows to little avail. The ... comfort and providing extra sleep." , They created a ... head, neck and back comfortably. This enables the user ...
Breaking Medicine News(10 mins):Health News:Hands On Mobile Massage and Spa of Long Island Now Offers a Spa-on-wheels 2Health News:NJ Top Docs Presents, The Plastic Surgery Group 2Health News:Tennessee Hyperbaric Center Offering HBOT Scholarships to Veterans 2Health News:Sleepless Nights, Exhausting Days, Mental Fog – Relief for Insomnia With Clinical Psychologist Dr. Carol Francis 2
... on how alcohol affects the brain in elderly people was ... senior citizens were investigated to discover the link between drinking ... alcohol is really a double-edged sword.// ,It has ... which ultimately has a negative impact on brain function. But ...
... Journal of the American Medical Association. Coronary heart disease ... diet supplement of folic acid alone or in combination ... at San Francisco and colleagues used the Coronary Heart ... lowering levels of homocystine through grains fortified with folic ...
... 45 and under too much of stress,a self-perpetuating cycle of ... times. The resulting weight gain often piles up around the ... applies to both sexes.// ,One doctor states, that people ... in midlife by learning when the body is vulnerable to ...
... antismoking segment with its "Smoquit" (buproprion 150mg tabs) recently. ... a decade as an antidepressant, albeit at a different ... pharmacotherapy ever available for the treatment of smoking problem, ... taken under medical supervision and guidance. // ...
... blood pressure causes inactivation of nitric oxide, a hormone ... If high blood pressure is left untreated, it does ... spiral out of control. According to the researchers at ... rats and found that nitric oxide, which helps control ...
... A new trial will compare digital mammography with the ... cancer earlier and with more accuracy. Standard film mammography ... radiographers are familiar with the scope and limitations of ... detect cancers in women with dense breast tissue, because ...
Cached Medicine News:
The Linvatec UltraFix Suture Anchor System's smooth surface until deployed eliminates tissue, bone and suture damage and its ultra smooth eyelet hole preserves suture integrity....
... The requirements for Bi-Plane Electrophysiology imaging have ... decrease procedure time and reduce radiation exposure ... paramount in deciding between Single and Bi-Plane ... of maintaining its leadership position in price/value ...
... Millbrook Practice Manager® is now known ... (PM). Centricity Physician Office - PM is ... and structure, providing an easily adaptable solution ... physician offices of every specialty and ...
... PrimeChart™ is the Point-of Care Electronic ... for an automated encounter documentation process and ... to use interface that is both mobile ... interface technologies, such as pentop technology with ...
Medicine Products: